Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Melanotropin or eledoisin; related peptides
Reexamination Certificate
2007-02-13
2007-02-13
Kam, Chih-Min (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Melanotropin or eledoisin; related peptides
C530S317000, C530S321000, C530S300000, C530S328000, C530S329000, C514S009100, C514S011400, C514S012200, C514S015800, C514S016700, C514S018700, C424S009100, C436S811000
Reexamination Certificate
active
10638071
ABSTRACT:
A cyclic peptide with a C-terminus —OH group. Further provided are compositions and methods for treatment of sexual dysfunction in mammals, including male sexual dysfunction, such as erectile dysfunction, and female sexual dysfunction, by administration of a cyclic peptide including a C-terminus —OH group. Methods of administration include injection, oral, urethral, vaginal, nasal and mucosal administration.
REFERENCES:
patent: 3853836 (1974-12-01), Greven
patent: 3862928 (1975-01-01), De Wied et al.
patent: 4649191 (1987-03-01), Hruby
patent: 4696913 (1987-09-01), Geiger et al.
patent: 5420109 (1995-05-01), Suto et al.
patent: 5569647 (1996-10-01), Fauchere et al.
patent: 5576290 (1996-11-01), Hadley
patent: 5674839 (1997-10-01), Hruby et al.
patent: 5693608 (1997-12-01), Bechgaard et al.
patent: 5714576 (1998-02-01), Hruby et al.
patent: 5731408 (1998-03-01), Hadley et al.
patent: 5908825 (1999-06-01), Fasano et al.
patent: 5977070 (1999-11-01), Piazza et al.
patent: 6051555 (2000-04-01), Hadley
patent: 6054556 (2000-04-01), Huby et al.
patent: 6579968 (2003-06-01), Blood et al.
patent: 6794489 (2004-09-01), Blood et al.
patent: 2 691 465 (1993-11-01), None
patent: 2 735 131 (1996-12-01), None
patent: WO94/22460 (1994-10-01), None
patent: WO99/21571 (1999-05-01), None
patent: WO99/43709 (1999-09-01), None
patent: WO99/55679 (1999-11-01), None
patent: WO99/64002 (1999-12-01), None
patent: WO03/006620 (2003-01-01), None
Miklós Lōw, et al., “Role of Chain Termini in Selective Steroidogenic Effect of ACTH/MSH(4-10) on Isolated Adrenocortical Cells”,Peptides, 1990, pp. 29-31, vol. 11.
Maria A. Bednarek, et al., “Structure-function studies on the cyclic peptide MT-II, lactam derivative of a-melanotropin”,Peptides, 1999, pp. 401-409, vol. 20.
Mac E. Hadley, et al., “Melanocortin Receptors: Identification and Characterization by Melanotropic Peptide Agonists and Antagonists”,Pigment Cell Research, Sep. 1996, pp. 213-234.
Carrie Haskell-Luevano, et al., “Discovery of Prototype Peptidomimetic Agonists at the Human Melanocortin Receptors MC1R and MC4R”,Journal of Medicinal Chemistry, 1997, pp. 2133-2138, vol. 40, No. 14.
Victor J. Hruby, et al., “Cyclic Lactam a-Melanotropin Analogues of Ac-Nle4-cyclo[Asp5, D-Phe7, Lys10] a-Melanocyte-Stimulating Hormone-(4-10)-NH2with Bulky Aromatic Amino Acids at Position 7 Show High Antagonist Potency and Selectivity at Specific Melanocortin Receptors”,Journal of Medicinal Chemistry, 1995, pp. 3454-3461, vol. 38.
Helgi B. Schiöth, et al., “Discovery of novel melanocortin4receptor selective MSH analogues”,British Journal of Pharmacology, 1998, pp. 75-82, vol. 124.
Helgi B. Schiöth, et al., “Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes”,European Journal of Pharmacology, 1998, pp. 359-366, vol. 349.
Hunter Wessells, et al., “Synthetic Malanotropic Peptide Initiates Erections in Men with Psychogenic Erectile Dysfunction; Double-Blind, Placebo Controlled Crossover Study”,The Journal of Urology, Aug. 1998, pp. 389-393, vol. 160.
John Donlon. et al., “The Production of Biological Active Peptides in Brain Tissues”,Metabolism of Brain Peptides, 1995, CRC Press, Inc., Boca Raton, Florida.
Gerard O'Cuinn, et al., “Neuropeptide Inactivation by Peptidases”,Metabolism of Brain Peptides, 1995, CRC Press, Inc., Boca Raton, Florida.
Rajpurohit Ramesh
Shadiack Annette
Sharma Shubh
Yang Wei
Kam Chih-Min
Palatin Technologies Inc.
Slusher Stephen A.
LandOfFree
Cyclic peptide compositions and methods for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic peptide compositions and methods for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic peptide compositions and methods for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3869523